Abstract:Butyrate is an abundant metabolite produced by gut microbiota. While butyrate is a known histone deacetylase inhibitor that activates expression of many genes involved in immune system pathways, its effects on virus infections and on the antiviral type I interferon (IFN) response have not been adequately investigated. We found that butyrate increases cellular infection with viruses relevant to human and animal health, including influenza virus, reovirus, HIV-1, human metapneumovirus, and vesicular stomatitis virus. Mechanistically, butyrate suppresses levels of specific antiviral IFN-stimulated gene (ISG) products, such as RIG-I and IFITM3, in human and mouse cells without inhibiting IFN-induced phosphorylation or nuclear translocation of the STAT1 and STAT2 transcription factors. Accordingly, we discovered that although butyrate globally increases baseline expression of more than 800 cellular genes, it strongly represses IFN-induced expression of 60% of ISGs and upregulates 3% of ISGs. Our findings reveal that there are differences in the IFN responsiveness of major subsets of ISGs depending on the presence of butyrate in the cell environment, and overall, they identify a new mechanism by which butyrate influences virus infection of cells.IMPORTANCE Butyrate is a lipid produced by intestinal bacteria. Here, we newly show that butyrate reprograms the innate antiviral immune response mediated by type I interferons (IFNs). Many of the antiviral genes induced by type I IFNs are repressed in the presence of butyrate, resulting in increased virus infection and replication. Our research demonstrates that metabolites produced by the gut microbiome, such as butyrate, can have complex effects on cellular physiology, including dampening of an inflammatory innate immune pathway resulting in a proviral cellular environment. Our work further suggests that butyrate could be broadly used as a tool to increase growth of virus stocks for research and for the generation of vaccines.

Commensal Microbiota Modulation of Natural Resistance to Virus Infection

Commensal bacteria promote type I interferon signaling to maintain immune tolerance in mice

The gut microbiota prime systemic antiviral immunity via the cGAS-STING-IFN-I axis

Microbiota regulates immune defense against respiratory tract influenza A virus infection

Commensal bacteria inhibit viral infections via a tryptophan metabolite

A Human Commensal-Pathogenic Fungus Suppresses Host Immunity Via Targeting TBK1

Commensal viruses maintain intestinal intraepithelial lymphocytes via noncanonical RIG-I signaling

[Commensal bacteria prevent pathogenic bacterial infection by inducing of activation of host immune system]

IFN-I and IL-22 mediate protective effects of intestinal viral infection

The intestinal microbiome and Cetobacterium somerae inhibit viral infection through TLR2-type I IFN signaling axis in zebrafish

Commensal enteric bacteria lipopolysaccharide impairs host defense against disseminated Candida albicans fungal infection

The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-[gamma]

Human gut commensal modulates the host lipidome and delivers anti-inflammatory outer membrane vesicles to suppress colitis in an -deficient mouse model

Extracellular vesicles produced by the human gut commensal bacterium Bacteroides thetaiotaomicron elicit anti-inflammatory responses from innate immune cells

Extracellular vesicles produced by the human commensal gut bacterium Bacteroides thetaiotaomicron affect host immune pathways in a cell‐type specific manner that are altered in inflammatory bowel disease

Interaction with mammalian enteric viruses alters outer membrane vesicle production and content by commensal bacteria

Activation of Immune and Defense Responses in the Intestinal Mucosa by Outer Membrane Vesicles of Commensal and Probiotic Escherichia coli Strains

Bacterial vesicles block viral replication in macrophages via TLR4-TRIF-axis

Ginsenoside Rg3 enriches SCFA-producing commensal bacteria to confer protection against enteric viral infection via the cGAS-STING-type I IFN axis

Butyrate Reprograms Expression of Specific Interferon-Stimulated Genes

A defined commensal consortium elicits CD8 T cells and anti-cancer immunity